Clinical trial

Drug Utilisation of Mysimba/Contrave

NCT06089824

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-09-01

PhaseN/A

Study timeline

Study start (actual)2014-09-01Date precision: month

Registry last updated2023-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Sponsors & collaborators

Currax Pharmaceuticalslead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06089824 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.